Xikun Wu
About Xikun Wu
Xikun Wu is the Senior Director of Statistics for Research and Manufacturing at BeiGene in Shanghai, China, with extensive experience in biostatistics and bioinformatics across multiple pharmaceutical companies.
Title
Xikun Wu serves as the Senior Director of Statistics for Research and Manufacturing at BeiGene. In this role, he leads a team that supports preclinical drug discovery, translational science, clinical biomarker, manufacturing, and product development.
Current Role at BeiGene
Xikun Wu has been with BeiGene since July 2019 in his capacity as Senior Director, Statistics for Research and Manufacturing. His responsibilities include leading a team that supports various aspects of drug development and manufacturing. His work is based in Shanghai, China.
Former Positions at Janssen Pharmaceutical Companies
Before joining BeiGene, Xikun Wu worked at The Janssen Pharmaceutical Companies of Johnson & Johnson as an Associate Director in Statistics & Decision Sciences. He held this position from 2017 to 2019, focusing on statistical analysis and decision science within the pharmaceutical field, based in Shanghai, China.
Former Role at Eli Lilly and Company
From 2014 to 2017, Xikun Wu was employed by Eli Lilly and Company as a Principal Scientist II at the Lilly China R&D Center in Shanghai, China. In this role, he contributed to research and development initiatives, particularly in biostatistics and bioinformatics.
Educational Background
Xikun Wu has an extensive educational background. He earned a PhD in Bioinformatics from Imperial College London (2003-2007), an MS in Applied Statistics from the University of Oxford (2002-2003), an MS in Bioinformatics from the University of Exeter (2000-2001), and a BS in General Biology from Nankai University (1995-1999). His early education includes studying at 沈阳二中 (1992-1995) and 沈阳七中 (1989-1992).